Eagle Pharma Outsourcing LLC: PHENYLephrine HCL Infusion, 100 mg per 250 mL in 0.9% Sodium Chloride (0.4 mg/mL), Sterile, Rx Only, Single-Use Container, EAGLE PHARMA OUTS
- Recall status
- Ongoing (still active)
- Severity
- Class II: could cause temporary or reversible health problems What recall classes mean
- Where sold
- Nationwide within the U.S
Common questions
- Is Eagle Pharma Outsourcing PHENYLephrine HCL Infusion 100 mg per 250 mL in 0.9% recalled?
- Yes. FDA (drug) recalled Eagle Pharma Outsourcing PHENYLephrine HCL Infusion 100 mg per 250 mL in 0.9% on 2026-11-04. Recall status: Ongoing (still active).
- What is the hazard?
- Lack of Assurance of Sterility
- Where was it sold?
- Nationwide within the U.S
Read the official notice at FDA (drug) →
Is Eagle Pharma Outsourcing recalled?
More recalls
- Eagle Pharma Outsourcing LLC: OXYTOCIN, 30 USP UNITS, Added to 0.9% Sodium
- bioQuad Life Sciences: OsteoDenx capsules
- Game Changer Products, LLC: 10 Day Forecast Capsules 3200mg
- Eugia US LLC: Vancomycin Hydrochloride for Injection USP 1.25g/Vial-30mL (Single
- Trifluent Pharma LLC: Tridacaine III / Lidocaine Patch 5%, 15 envelopes
The text below is copied from the official FDA (drug) record. If anything differs, the official notice is correct.
- Company / brand
- Eagle Pharma Outsourcing LLC
- Product
- PHENYLephrine HCL Infusion, 100 mg per 250 mL in 0.9% Sodium Chloride (0.4 mg/mL), Sterile, Rx Only, Single-Use Container, EAGLE PHARMA OUTSOURCING, 2200 Riverchase Center, Suite 675, Hoover, AL 35244, UPC: 6985210025. NDC 69852-100-25
- Reason / hazard
- Lack of Assurance of Sterility
- What to do (remedy)
- Classification
- Class II
- Status
- Ongoing
- Distribution / sold at
- Nationwide within the U.S
- Recall initiated
- 2026-10-08
- Code info
- Lot: PHENYL100-1004, Expiry: 12/31/2026.
- Product quantity
- 50 250 mL-containers
- Voluntary mandated
- Voluntary: Firm initiated
- City
- Hoover
- State
- AL
- Country
- United States
- Event id
- 100073
Free daily digest + "My products" watchlist